QIAGEN to acquire Parse Biosciences

Entering the age of single-cell AI

07-Nov-2025 - QIAGEN announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a provider of scalable, instrument-free solutions for single-cell research. The acquisition will significantly expand QIAGEN’s Sample technologies portfolio into the fast-growing single-cell sequencing ...